Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: Case report and review of the literature

References

• Loftus EV, Tremaine WJ, Habermann TM, Harmsen WS, Zinmeister AR, Sandborn WJ. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000; 95: 2308–12
   PubMed Web of Science ®Google Scholar
• Perosio PM, Brooks JJ, Saul SH, Haller DG. Primary intestinal lymphoma in Crohn's disease: minute tumor with a fatal outcome. Am J Gastroenterol 1992; 87: 894–8
   PubMed Web of Science ®Google Scholar
• Glick SN, Teplick SK, Goodman LR, Clearfield HR, Shanser T. Development of lymphoma in patients with Crohn's disease. Radiology 1984; 153: 337–9
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991; 67: 2015–19
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Mullin GE, Srauchen JA, Heinmann T, Janowitz HD, Aufses AH Jr, et al. Lymphoma in inflammatory bowel disease. Cancer 1992; 69: 1119–23
   PubMed Web of Science ®Google Scholar
• Christodoulou DK, Katsanos KH, Tzambouras N, Baltayiannis G, Tsianos EV. Efficacy and safety of azathioprine in inflammatory bowel disease. Hepatogastroenterology 2003; 50: 1021–4
   PubMedGoogle Scholar
• Rutgeerts P, D’ Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, et al. Efficacy and safety of treatment with anti-tumor necrosis factor antibody (Infliximab) to maintain remission in Crohn's disease. Gastroenterology 1999; 117: 761–9
   PubMed Web of Science ®Google Scholar
• Vanbockrijck M, Cabooter M, Casselman J, Vanvuchelen J, Hoof A, Michielssen P. Primary Hodgkin disease of the ileum complicating Crohn's disease. Cancer 1993; 72: 1784–9
   PubMed Web of Science ®Google Scholar
• Collins WJ. Malignant lymphoma complicating regional enteritis. Am J Gastroenterol 1977; 68: 177–81
   PubMed Web of Science ®Google Scholar
• Codling BW, Keighley MRB, Slaney G. Hodgkin's disease complicating Crohn's colitis. Surgery 1977; 82: 625–8
   PubMed Web of Science ®Google Scholar
• Hecker R, Sheers R, Thomas D. Hodgkin's disease as a complication of Crohn's disease. Med J Aust 1978; 2: 603
   PubMed Web of Science ®Google Scholar
• Li S, Borowitz MJ. Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease. Arch Pathol Lab Med 2001; 125: 424–7
   PubMed Web of Science ®Google Scholar
• Sivarajasingham N, Adams SA, Smith ME, Hosie KB. Perianal Hodgkin's lymphoma complicating Crohn's disease. Int J Colorectal Dis 2003; 18: 174–6
   PubMed Web of Science ®Google Scholar
• Kumar S, Fend F, Quintanilla-Martinez L, Kingma DW, Sorbara L, Raffeld M, et al. Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression. Am J Surg Pathol 2000; 24: 66–73
   PubMed Web of Science ®Google Scholar
• Morrison PD, Whittaker M. A case of Hodgkin's disease complicating Crohn's disease. Clin Oncol 1982; 8: 271–2
   PubMed Web of Science ®Google Scholar
• Shaw JH, Mulvaney N. Hodgkin's lymphoma: a complication of small bowel Crohn's disease. Aust NZ J Surg 1982; 52: 34–6
   PubMedGoogle Scholar
• Kelly MD, Stuart M, Tschuchnigg M, Turner J, Tydd T. Primary intestinal Hodgkin's disease complicating ileal Crohn's disease. Aust NZ J Surg 1997; 67: 485–9
   PubMedGoogle Scholar
• Christodoulou D, Skopelitou A, Katsanos KH, Katsios C, Kappas A, Agnantis N, et al. Small bowel adenocarcinoma as first manifestation of Crohn's disease. Eur J Gastroenterol Hepatol 2002; 14: 805–10
   PubMed Web of Science ®Google Scholar
• Skopelitou A, Katsanos KH, Michail M, Mitselou A, Agnantis N, Tsianos EV. Immunohistochemical expression of FHIT gene product in inflammatory bowel disease in Northwest Greece. Eur J Gastroenterol Hepatol 2003; 15: 1–9
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Gennuso R, Sachar DB, Heinmann T, Smith H, Janowitz HD, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56: 2914–21
   PubMed Web of Science ®Google Scholar
• Connel WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jone JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249–52
   PubMed Web of Science ®Google Scholar
• Cottone M, Orlando A, Casa A, Oliva L. Maintenance infliximab for Crohn's disease. Lancet 2002; 359: 1602
   Google Scholar
• Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151–8
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Davidsen M, Binder V, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716–23
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Cancer risk in ulcerative colitis and Crohn's disease: strategies to avoid cancer deaths. Inflammatory bowel disease3rd ed, RN Allan, JM Rhodes, SB Hanauer, MRB Keighley, J Alexander-Williams, VW Fazio. Churchill Livingstone, London 1997; 675–82
   Google Scholar
• Katsanos KH, Christodoulou D, Zioga A, Dimou S, Tsianos EV. Cutaneous nevi pigmentosus during Infliximab therapy in a Crohn's disaease patient. Inflam Bowel Dis 2003; 9: 279
   PubMed Web of Science ®Google Scholar
• Losco A, Giannelli U, Cassani B, Boldini L, Conte D, Basilisco G. Epstein-Barr virus-associated lymphoma in Crohn's disease. Inflamm Bowel Dis 2004; 10: 425–9
   PubMed Web of Science ®Google Scholar
• Bai MC, Jiwa NM, Horstman A, Vos W, Kluin PH, Van der Valk, et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994; 174: 49–55
   PubMed Web of Science ®Google Scholar